Dr. Noureddin Sawan and his team from the Cardiology Department at The View Hospital.
Doha, Qatar: The View Hospital, in affiliation with Cedars-Sinai, is proud to announce a groundbreaking achievement, having successfully performed the first pulmonary vein isolation procedure and the first electrophysiology (EP) study in Qatar’s private healthcare sector.
Carried out by Dr. Noureddin Sawan, cardiology consultant in Interventional Electrophysiology, and his highly skilled team from the Cardiology Department at The View Hospital, this advanced procedure provides a revolutionary treatment option for patients suffering from atrial fibrillation (AFib), a common heart rhythm disorder.
By using state-of-the-art technology, the procedure isolates the pulmonary veins to interrupt abnormal electrical signals in the heart, restoring normal rhythm and significantly improving the quality of life for patients.
Pulmonary vein isolation is widely recognised as a highly effective and minimally invasive technique for managing AFib, reducing symptoms, and lowering the risk of complications such as stroke and heart failure. This milestone underscores The View Hospital’s commitment to bringing cutting-edge treatments to Qatar’s private healthcare sector, positioning the hospital as a pioneer in the field of cardiovascular care.
Dr. Fatih Mehmet Gul, CEO of The View Hospital, said, “The successful implementation of this procedure is a testament to the expertise and dedication of our exceptional team. It underscores The View Hospital’s role as an academic centre, providing tertiary-level care services of the highest standard. We are proud to be the first in Qatar’s private healthcare sector to offer this groundbreaking treatment, reaffirming our commitment to delivering the most advanced medical care to our patients.”
This milestone further solidifies The View Hospital’s leadership in medical innovation, enhancing the range of specialized services offered in Qatar’s private healthcare sector.
It highlights the hospital’s ongoing commitment to advancing patient outcomes and offering life-changing treatments to those in Qatar and the region.
